Accessibility Menu
BIO-key International logo

BIO-key International

(OTC) BKYI

Current Price$38.61
Market Cap$323.92M
Since IPO (1997)-100%
5 Year+234%
1 Year+81%
1 Month+2%

BIO-key International Financials at a Glance

Market Cap

$323.92M

Revenue (TTM)

$6.63M

Net Income (TTM)

-$4.02M

EPS (TTM)

$1.16

P/E Ratio

33.61

Dividend

$0.00

Beta (Volatility)

0.47 (Low)

Price

$38.61

Volume

941.697

Open

$39.16

Previous Close

$39.12

Daily Range

$38.61 - $39.16

52-Week Range

$17.73 - $40.99

Estimated Earnings Date

May 20, 2026

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BIO-key International

Industry

Software

Employees

42

CEO

Michael W. DePasquale

Headquarters

Holmdel, NJ 07719, US

BKYI Financials

Key Financial Metrics (TTM)

Gross Margin

77.84%

Operating Margin

-56.34%

Net Income Margin

-60.58%

Return on Equity

-57.42%

Return on Capital

-55.20%

Return on Assets

-37.62%

Earnings Yield

2.98%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$323.92M

Shares Outstanding

8.28M

Volume

941.697

Avg. Volume

57.60K

Financials (TTM)

Gross Profit

$5.16M

Operating Income

-$3.74M

EBITDA

-$3.53M

Operating Cash Flow

-$4.19M

Capital Expenditure

-$7.44K

Free Cash Flow

-$4.19M

Cash & ST Invst.

$2.25M

Total Debt

$42.41K

BIO-key International Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$2.15M

+33.5%

Gross Profit

$1.77M

+33.3%

Gross Margin

82.46%

N/A

Market Cap

$323.92M

N/A

Market Cap/Employee

$7.90M

N/A

Employees

41

N/A

Net Income

-$165.04K

+77.6%

EBITDA

-$137.87K

+77.1%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$2.25M

-28.3%

Total Debt

$42.41K

-95.7%

Accounts Receivable

$1.57M

+86.5%

Inventory

$338.40K

-5.4%

Long Term Debt

$12.91K

-76.1%

Short Term Debt

$29.50K

-96.8%

Return on Assets

-37.62%

N/A

Return on Invested Capital

-49.78%

N/A

Free Cash Flow

-$358.00K

+57.4%

Operating Cash Flow

-$358.00K

+57.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BAERBridger Aerospace Group Holdings, Inc. Common Stock
$1.72-0.00%
SUNESUNation Energy Inc.
$2.49-2.35%
RVSNRail Vision Ltd.
$4.42-1.34%
CIGLConcorde International Group Ltd Class A Ordinary Shares
$1.99+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
WENWendy's
$8.71+0.11%
FCUVFocus Universal
$5.95+0.35%
TECHBio-Techne
$70.17+0.19%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$38.00-0.06%

Questions About BKYI

What is the current price of BIO-key International?

BIO-key International is trading at $38.61 per share.

What is the 52-week range for BIO-key International?

Over the past 52 weeks, BIO-key International has traded between $17.73 and $40.99.

How much debt does BIO-key International have?

As of the most recent reporting period, BIO-key International reported total debt of $706.70K.

How much cash does BIO-key International have on hand?

BIO-key International reported $2.25M in cash and cash equivalents in its most recent financial results.

What is BIO-key International’s dividend yield?

BIO-key International does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.